Abstract |
Guanine ribonucleosides substituted at the 8 position of the guanine ring are a unique class of immunomodulators, the lead compound of which is 7-allyl-8-oxoguanosine ( loxoribine). We conducted a double-blind randomized phase I study to evaluate the safety, pharmacokinetics, and immunologic effects of single ascending doses of loxoribine in patients with advanced cancer. Twenty-four patients were treated in three dose tiers of 8 patients each, utilizing a unique statistical design, so that within each group, patients were randomized in blocks of 4 to receive loxoribine initially and then placebo 4 weeks later--a sequence that was reversed in the remaining 4 patients. In 23 courses of loxoribine and 20 courses of placebo, toxicity was mild and infrequent at all dose tiers (1 mg/kg, 5 mg/kg and 10 mg/kg. Both antibody-dependent cellular cytotoxicity and lymphokine-activated killer cytotoxicity were transiently depressed following loxoribine administration at all doses. Loxoribine is safe at doses up to 10 mg/kg in patients with advanced cancer, and produces modest immunologic effects. Further testing, particularly in conjunction with other immunologic agents, is warranted.
|
Authors | S S Agarwala, J M Kirkwood, J Bryant |
Journal | Cytokines, cellular & molecular therapy
(Cytokines Cell Mol Ther)
Vol. 6
Issue 4
Pg. 171-6
(Dec 2000)
ISSN: 1368-4736 [Print] England |
PMID | 11565955
(Publication Type: Clinical Trial, Clinical Trial, Phase I, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Adjuvants, Immunologic
- Guanosine
- loxoribine
|
Topics |
- Adjuvants, Immunologic
(pharmacokinetics, therapeutic use)
- Adult
- Aged
- Disease Progression
- Dose-Response Relationship, Drug
- Double-Blind Method
- Female
- Guanosine
(analogs & derivatives, pharmacokinetics, therapeutic use)
- Humans
- Killer Cells, Natural
(metabolism)
- Leukocytes, Mononuclear
(metabolism)
- Lymphocytes
(metabolism)
- Male
- Middle Aged
- Models, Chemical
- Neoplasms
(drug therapy)
- Time Factors
- Tumor Cells, Cultured
|